To whom is the cancer committee required to distribute its report on patient or program outcomes?

The cancer committee is required to distribute its report on patient or program outcomes to the public to ensure transparency and accountability in cancer care. This practice aligns with the Commission on Cancer’s standards, which emphasize the importance of making quality-of-care information accessible to the community. By sharing outcomes publicly, the cancer program not only informs patients and their families about the quality of care they may receive but also fosters trust within the community. It allows for greater engagement and awareness of cancer care, which can lead to improved health outcomes and informed choices among patients.

This distribution can also encourage a culture of continuous improvement within the organization, as public feedback and scrutiny can drive initiatives aimed at enhancing care delivery and patient experiences. Overall, prioritizing transparency through reports to the public is essential in promoting a high standard of oncology care.